Incidence of Cognitive Impairments in Cohorts with Longitudinal Evaluation in Parkinson’s disease

ICICLE-PD
Incidence of Cognitive Impairments in Cohorts with Longitudinal Evaluation in Parkinson’s disease

[email protected]
Parkinson’s UK
Parkinson’s UK

Only through study| Through links to medical records

United Kingdom

Yes
Apply to PI or co-ordinator at resource| Access independent of PI| National access| International access| Access for pilot studies permitted

Yes
Living donors: blood| Living donors: blood derivatives| Living donors: DNA| Living donors: cerebro-spinal fluid
Primary Samples: Stabilised samples (frozen or fixed)| Secondary samples: plasma| Secondary samples: DNA| Secondary samples: RNA
Yes
Yes, for all the cohort

1-1,000

Queen’s Square Brain Bank Criteria, medical history, social history, Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Part II and III, Hoehn and Hahr stage.
Yes, including Non-Motor System Questinniare, Geriatric Depression Scale, Epworth Daytime Sleepiness Scale, Pitsburg Sleep Quality Index, Parkinson’s Disease Questionnaire (PDQ-39) and neuropsychological test.
Yes
Diagnosis of dementia
Prospective cohort
Age| Sex
No

Data collection ongoing| Data analysis ongoing| Closed to new patients
No

Data summarised in database

Database is web-based

Database on spreadsheet (e.g. excel)

No

No

No

Incidence of Cognitive Impairments in Cohorts with Longitudinal Evaluation in Parkinson’s disease
Parkinson’s disease

Case Control Studies
United Kingdom
Parkinson’s disease & PD-related disorders
2016

 

 

Post
Filter